Resultados de la búsqueda 451-460 de 3455 para anti-TNF drugs
Gender-affirming hormone therapy (adult). Mayo Clinic; 2022. Nippoldt TB (expert opinion). Mayo Clinic. Feb. 7, 2024. Relacionado. Disforia de género ...
Anti-cancer activity will be assessed every 6 weeks during therapy and every 12 weeks thereafter. Establishment of Preclinical Models from Patients with ...
The purpose of this study is to compare two types of surgery for the treatment of uterovaginal prolapse to determine which surgery works best from a ...
... treatment. A Study to Evaluate Potential Myocardial Injury Following Magnetic Resonance Imaging (MRI). Rochester, Minn. The purpose of this study is to ...
... treatment, post-treatment and (when available) post-mortem soft tissue sarcoma (STS) tissue and tissue data with an emphasis on STSs occurring in younger ...
To determine the effectiveness of the ARTISAN Aphakia lens in the treatment of aphakia and to precisely define the associated risks and, if possible, identify ...
Drugs that kill "zombie" cells may benefit some older women, but not all ... Hormone therapy: Four things a Mayo Clinic women's health specialist wants ...
Giving vinorelbine and VAC may kill more tumor cells. Adding maintenance therapy (vinorelbine and cyclophosphamide) after VAC therapy, with or without ...
News · julio 2024 · junio 2024 · mayo 2024 · abril 2024 · marzo 2024 · febrero 2024 · enero 2024 · diciembre 2023.
A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?